Trial Profile
Exploratory clinical trial of the new 4th line Helicobacter pylori eradication therapy using vonoprazan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2021
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Amoxicillin; Rifabutin
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 30 Mar 2019 Status changed from recruiting to completed.
- 04 Sep 2015 New trial record